
An explosion has occurred at the Israel Centre in Nijkerk to the east of Amsterdam in the Netherlands, Dutch media reported on Saturday.
No one was injured in the blast, which took place late on Friday, the ANP news agency reported, citing police. Damage was reported to be limited.
Police appealed for information and said they were investigating. No arrests were made initially.
On its website, the organization describes the building as a meeting point for Christians with feelings of affection for Israel: "Our mission is to bring Biblical understanding in the Church concerning God's purposes for Israel and to promote comfort of Israel through prayer and action."
According to a report in the Dutch daily Trouw, the centre has in the recent past repeatedly been a target of protests by pro-Palestinian groups during which damage to property has been recorded.
latest_posts
- 1
The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it. - 2
Many European nations want Israel to cancel 19 new settlement plans - 3
Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth - 4
Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road - 5
'Malcolm in the Middle' reboot releases 1st trailer, reuniting Frankie Muniz and Bryan Cranston: Watch here
At least 30 killed in attack on Nigeria village
Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
Amateur's Manual for Venture Strategies for Tenderfoots
The Most Important Crossroads in Olympic History
The most effective method to Pick the Right Material Organization: Your Definitive Aide
New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix
IDF strikes terror infrastructure across Iran, attack reported on Kashan airport
Pulsars to the extreme: Spinning dead stars found blasting radio signals from the 'edge of their magnetic reach'
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial













